Use of a Social Assistance Robot in a Population of Children Subjected to Prolonged Isolation

NCT ID: NCT06405620

Last Updated: 2024-05-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

33 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-06-01

Study Completion Date

2026-01-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

During the period of isolation of the hospitalized child, contacts between the child and his family are impaired. Being away from home as well as from the social and family circle can be harmful for the hospitalized child. It seems necessary to measure the impact of the use of such an assistance robot both on the user himself and his family. Thus, it seems relevant to scientifically validate the benefit of using such an assistance robot to break iatrogenic social isolation and to measure the impact of this use.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Social Isolation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Robot intervention

the child uses the assistance robot

Group Type EXPERIMENTAL

Assistance robot

Intervention Type OTHER

the child controls the robot at his parent's home from his room

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Assistance robot

the child controls the robot at his parent's home from his room

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Children hospitalized in the pediatric hemato-oncology department whose duration of isolation is estimated to be greater than two weeks.
* Children who have accepted the robot and whose parents have accepted its use in their home.
* Agreement of holders of parental authority for the inclusion of the hospitalized child.

Exclusion Criteria

* Patient or two parents who do not have a sufficient level of French for research.
* Cognitive or motor disorders in children, not allowing the use of the robot and/or the carrying out of semi-structured interviews.
* Cognitive disorders in parents and/or siblings that do not allow semi-structured interviews to be carried out.
Minimum Eligible Age

7 Years

Maximum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Toulouse

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Rémi IZOULET

Role: PRINCIPAL_INVESTIGATOR

Toulouse Hospital

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Nadege ALGANS

Role: CONTACT

0561777204

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

RC31/23/0168

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.